Point-of-Care Glucose Testing Market Forecast 2025-2034: Comprehensive Analysis And Growth Opportunities

The Point-of-Care Glucose Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].

What Is the Projected Growth of the Point-of-Care Glucose Testing Market?
The market size for point-of-care glucose testing has seen consistent growth over the recent years. The market value is projected to increase from $4.91 billion in 2024 to $5.15 billion in 2025, with an annual growth rate of 4.9%. The historical growth can be linked to factors such as the increasing incidence of diabetes, heightened awareness around diabetes management, growth of the older population, expansion in healthcare infrastructure, and embracing of point-of-care testing.

In the coming years, it is anticipated that the point-of-care glucose testing market will experience robust growth, reaching a size of $6.51 billion in 2029 with a compound annual growth rate (CAGR) of 6.0%. This growth during the forecast period can be linked to the proliferation of telemedicine services, the heightened focus on individualized diabetes care, increased diabetes management programs, escalated investments in glucose testing research and development and the employment of continuous glucose monitoring. Significant trends within this forecast period include the creation of wearable glucose monitoring gadgets, inclusion of smartphone connectivity in glucose testing, the increased prevalence of home healthcare point-of-care testing, the incorporation of artificial intelligence in analyzing glucose data, and the surge of remote patient supervision for diabetes.

Purchase the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=12207

What Are the Different Point-of-Care Glucose Testing Market Segments?
The point-of-care glucose testing market covered in this report is segmented -

1) By Product: Lancet And Lancing Devices, Strips, Meters
2) By Testing Site: Fingertips, Alternate Site Testing
3) By Applications: Type-1 Diabetes, Type-2 Diabetes
4) By End-User: Professional Diagnostic Centers, Hospitals And Clinics, Home Care Settings, Other End Users

Subsegments:
1) By Lancet And Lancing Devices: Single-Use Lancets, Multi-Use Lancets, Adjustable Lancing Devices
2) By Strips: Glucose Test Strips, ket*one Test Strips, Combo Strips (Glucose And ket*one)
3) By Meters: Blood Glucose Meters, Continuous Glucose Monitoring (CGM) Meters, Bluetooth-Enabled Meters

Get your free sample here:
https://www.thebusinessresearchcompany.com/sample.aspx?id=12207&type=smp

What Are the Primary Drivers Shaping the Point-of-Care Glucose Testing Market?
The expanding incidence of diabetes is anticipated to fuel the progress of the point-of-care glucose testing market. Diabetes, which is a persistent metabolic disorder, elevates the amount of glucose in the blood, which can, over time, lead to severe damage to major organs such as the heart, blood vessels, eyes, kidneys, and nerves. Point-of-care glucose testing is widely used in determining glucose levels in hospitalized patients, enabling quick treatment plans based on changes in glycemia, and improving therapy results and diabetes management. For example, The National Health Service (NHS England) reported in June 2024, that in 2023, the UK-based publicly-funded healthcare system detected an increase in pre-diabetes individuals to 3,615,330, which is an 18% rise from 3,065,825 in 2022. Furthermore, there was a nearly 25% spike in cases among individuals under 40, increasing from 173,166 in 2022 to 216,440 in 2023. Consequently, the escalating prevalence of diabetes is a key factor driving the advancement of the point-of-care glucose testing market.

Which Companies Are Leading in the Point-of-Care Glucose Testing Market?
Major companies operating in the point-of-care glucose testing market include F Hoffmann-La Roche Ltd., Abbott Laboratories Inc., Danaher Corporation, Siemens Healthineers, Becton, Dickinson and Company, TaiDoc Technology Corporation, B. Braun Melsungen AG, Beckman Coulter Inc., Nipro Corporation, Dexcom Inc., Bio-Rad Laboratories Inc., LifeScan Inc., Nova Biomedical Corporation, Ypsomed AG, Ascensia Diabetes Care Holdings AG, Trividia Health Inc., Radiometer Medical ApS, HemoCue AB, EKF Diagnostics Holdings plc, Trinity Biotech plc, Bionime Corporation, PTS Diagnostics, ForaCare Inc., Menarini Diagnostics, ACON Laboratories Inc., Senseonics Holdings Inc., Prodigy Diabetes Care LLC, Nemaura Medical Inc.

What Are the Major Trends Shaping the Point-of-Care Glucose Testing Market?
Product advancement is the foremost trend gaining traction in the point-of-care glucose testing market. Leading businesses in this sector are concentrating on creating pioneering products to reinforce their market standing. An exemplar occurred in January 2022 when F. Hoffmann-La Roche AG, a Swiss healthcare company, launched a new point-of-care blood glucose monitor named Cobas Pulse for medical professionals. This comes with an additional piece of equipment resembling a touchscreen smartphone that runs its functions. The Cobas Pulse is a portable tool equipped with an automatic glucose test strip reading function, camera, and touchscreen. This assist in recording diagnostic information and is encased in a durable shell that can be sanitized and applied to patients across all age brackets, inclusive of newborns and those in intensive care. Furthermore, it aims to enhance doctors' workflow by utilizing the Glucommander dosage software on the blood glucose reader and integrating downloadable decision-support apps from firms such as Smart4Diagnostics, CardioSignal, and SteadySense.

Get the full report for exclusive industry analysis:
https://www.thebusinessresearchcompany.com/report/point-of-care-glucose-testing-global-market-report

What Are the Top Revenue-Generating Geographies in the Point-of-Care Glucose Testing Market?
North America was the largest region in the point-of-care glucose testing market in 2024. The regions covered in the point-of-care glucose testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Frequently Asked Questions:
1. What Is the Market Size and Growth Rate of the Point-of-Care Glucose Testing Market?
2. What is the CAGR expected in the Point-of-Care Glucose Testing Market?
3. What Are the Key Innovations Transforming the Point-of-Care Glucose Testing Industry?
4. Which Region Is Leading the Point-of-Care Glucose Testing Market?

Why This Report Matters:

Competitive overview: This report analyzes the competitive landscape of the 3D imaging software market, evaluating key players on market share, revenue, and growth factors.

Informed Decisions: Understand key strategies related to products, segmentation, and industry trends.

Efficient Research: Quickly identify market growth, leading players, and major segments.

Connect with us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company,
Twitter: https://twitter.com/tbrc_info,
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ.

Contact Us
Europe: +44 207 1930 708,
Asia: +91 88972 63534,
Americas: +1 315 623 0293 or
Email: mailto:info@tbrc.info

Learn More About The Business Research Company
With over 15,000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Our flagship product, the Global Market Model delivers comprehensive and updated forecasts to support informed decision-making.

This release was published on openPR.